Apteka Łozowscysp. z o.o.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2006-07-25
Share capital
50,000.00 PLN
Registered address
ul. Kinga C. Gillette 11, 94-406 Łódź, Poland
Electronic delivery address
AE:PL-95206-12628-SIABW-18

Financials

Revenue history (in k)

Financial insight

  • Possible Estonian CIT: Equity includes Art. 28d line items, but all amounts are 0 – this may be an accounting template or the first year of the regime.

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 5 days late).

  • 202524/06/2026
  • 202415/06/2025
  • 202313/06/2024
  • 202216/06/2023
  • 202120/07/2022
  • 202024/05/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 5.41mMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD -62.61kMedianUSD 20.66kAverageUSD 86.62k
Operating costs
This companyUSD 5.31mMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 824.39kMedianUSD 544.32kAverageUSD 1.76m

National Health Fund (NFZ) contracts

Apteka Łozowscy has been an NFZ healthcare provider since 2019. In 2026 it is performing 3 contracts with a total value of USD 1.49k. All its contracts were worth USD 12.29k in total.

NFZ contract value by year (USD)

Type of careNFZ branchContractsValue in 2026
Pilot programmesmazowieckie1USD 1.49k
Other services provided in pharmacieslubelskie1USD 0.00
Other services provided in pharmaciesmazowieckie1USD 0.00

Authorized Representatives

Aleksandra Olszacka – Vice President of the Management Board
Bożena Helena Szymańska – President of the Management Board
Katarzyna Nockowska Stańczak – Vice President of the Management Board

Manner of representation

In the event of the appointment of a multi-member management board, the joint action of two members of the management board or of a member of the management board with a commercial proxy is required for the validity of declarations made on behalf of the company. The commercial proxy makes declarations on behalf of the company jointly with a member of the management board or, if joint commercial proxy has been granted, with another commercial proxy.

Ownership

OwnerSharesShare valueStake
500$13,506.21100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2006-10-01.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Fragalsp. z o.o.
Modrzewscysp. j.
Ms-Pharmsp. z o.o. + limited partnership
Farmjug Agsp. z o.o.
MagmaxS.A.
Adpharmasp. z o.o.
Alfa Pharm - Małgorzata Janusik, Jarosław Janusiksp. j.
Novopharm - Millersp. j.
Pikadasp. z o.o.
Awicennasp. j.

Change history

DateEvent
2024-09-24Address change
2018-02-09Address change
2015-07-19PKD change
2010-08-10Switch to PKD 2007
2006-07-25Entered in the register

FAQ

Last updated: 2026-10-07